在乳腺癌中识别与Trop2相关的生物标志物:针对性治疗的含义
Jianguo Lai1, Shuxuan Deng1,2, Jiyuan Cao1
1Department of Breast Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Discover oncology
|September 6, 2024
概括
在乳腺癌 (BC) 中Trop2 (TROP2) 过度表达和突变预测预后不佳和生存时间缩短. 这些发现突出了Trop2作为针对BC患者向治疗的潜在生物标志物.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- Trop2 (TROP2) 是一种细胞膜糖蛋白,在上皮癌中经常过度表达.
- 了解Trop2在乳腺癌 (BC) 中的作用对于开发向疗法至关重要.
研究的目的:
- 研究Trop2在乳腺癌中的突变特征.
- 确定Trop2表达和突变在乳腺癌预后中的临床意义.
主要方法:
- 分析了77名乳腺癌患者的Trop2表达和临床数据.
- 使用cBioPortal和Kaplan-Meier Plotter进行基因组改变和mRNA表达分析.
- 进行下一代测序来描述Trop2突变及其对其他基因的影响.
主要成果:
- 高Trop2表达和Trop2突变与较短的无疾病生存期 (DFS) 和无复发生存期 (RFS) 有关.
- 在96.1%的患者中观察到Trop2表达.
- 在Trop2表达组之间发现了MAP3K1,NOTCH2,PTEN和MAGI2突变频率的显著差异.
- Trop2突变影响了其他基因的表达,突变,甲基化和酸化,包括MED8,DPH2和KDM4A.
结论:
- Trop2表达和突变是乳腺癌预后不佳的预测生物标志物.
- 特定的基因突变 (MAP3K1,NOTCH2,PTEN,MAGI2) 在Trop2表达水平之间存在差异.
- Trop2对基因表达,变异,甲基化和酸化的影响为向疗法开发提供了洞察力.
更多相关视频
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.4K
07:42Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
7.9K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K